跳至主要内容
临床试验/CTRI/2023/03/050468
CTRI/2023/03/050468已完成Unknown

A COMPARATIVE STUDY OF SAFETY AND EFFICACY OF INTRAVENOUS CARBETOCIN VERSUS INTRAMUSCULAR CARBETOCIN INPREVENTION OF POSTPARTUM HEMORRHAGE DURING VAGINAL DELIVERY - A randomized parallel group trial.

DR SWATI TALWADE0 个研究点目标入组 134 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
134

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patient consenting for study .
  • 2.Term pregnancy (37 – 42 weeks of gestation) Expected to delivery vaginally

排除标准

  • 1.Elective cesarean section
  • 2.Have known allergies to Carbetocin, other Oxytocin homologs or excipients in the medicinal products used in the trial;
  • 3. Have cardiovascular disorders
  • 4. Hypertensive disorders
  • 5. Have hepatic or renal disease
  • 6. Have epilepsy
  • 7. Women with coagulopathies
  • 8. Women having known conditions predisposing to atonic PPH like hydramnios,multiple gestations, and prolonged labor etc.
  • 9.Are not willing to give consent

研究者

发起方
DR SWATI TALWADE

相似试验